News Releases

Date	Title
07/15/2024	Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System	PDF Version
07/02/2024	Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")	PDF Version
05/29/2024	Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")	PDF Version
05/07/2024	Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates	PDF Version
04/24/2024	Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024	PDF Version
04/11/2024	Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City	PDF Version
03/28/2024	Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference	PDF Version
03/12/2024	Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates	PDF Version
02/28/2024	Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024	PDF Version
01/23/2024	Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures	PDF Version

Keyword Search